Thymoquinone Induces Cytotoxicity and Reprogramming of EMT in Gastric Cancer Cells by Targeting PI3K/Akt/mTOR Pathway

Overview

Journal J Biosci

Specialties Biochemistry
Biology

Date 2017 Dec 13

PMID 29229873

Citations 25

Authors

Li-Min Feng

Xue-Feng Wang

Qing-Xian Huang

Affiliations

Soon will be listed here.

Abstract

Gastric cancer is one of the lethal causes of cancer-related deaths worldwide. The incidence and mortality rates of this disease is comparatively higher in China. In the current study, we evaluated the anticancer effects of Thymoquinone (TQ) against gastric cancer cells (MGC80-3 and SGC-7901) and normal noncancerous GES-1 cells and attempted to investigate the underlying mechanism. Our results indicated that TQ exhibited significant growth inhibitory effects on gastric cancer cells (MGC80-3 and SGC-7901). However, lower cytotoxicity was observed against normal GES-1 cells. Moreover, TQ could inhibit the colony formation potential of MGC80-3 and SGC-7901 cells in a dose-dependent manner. TQ also inhibited cell migration ability of the gastric cancer cells and down-regulated the expression of the mesenchymal genes such as , and TWIST. However, the epithelial markers such as E-cadherin and cytokeratin-19 were distinctly up-regulated in TQ-treated gastric cancer cells. Since PI3K/Akt/ mTOR plays an important role in progression and tumorigenesis, we also investigated the effect of TQ on PI3K/Akt/mTOR signalling pathway in gastric cancer cells. It was observed that TQ down-regulated the expression of some of the key proteins of this pathway. Taken together, we conclude that TQ may prove lead molecule for the treatment of gastric cancer.

Citing Articles

Potential role of thymoquinone to treat gastrointestinal cancers: insights into its molecular mechanisms.

Rahjoo T, Motamedzadeh A, Ferdosi F, Dadgostar E, Aschner M, Mirzaei H Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 40045027 DOI: 10.1007/s00210-025-03861-1.

Targeting Cancer Hallmarks Using Selected Food Bioactive Compounds: Potentials for Preventive and Therapeutic Strategies.

Talib W, Abed I, Raad D, Alomari R, Jamal A, Jabbar R Foods. 2024; 13(17).

PMID: 39272454 PMC: 11395675. DOI: 10.3390/foods13172687.

An Overview of the Spices Used for the Prevention and Potential Treatment of Gastric Cancer.

Kostelecka K, Brylinski L, Komar O, Michalczyk J, Milosz A, Bilogras J Cancers (Basel). 2024; 16(8).

PMID: 38672692 PMC: 11049028. DOI: 10.3390/cancers16081611.

Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer.

Morgos D, Stefani C, Miricescu D, Greabu M, Stanciu S, Nica S Int J Mol Sci. 2024; 25(3).

PMID: 38339127 PMC: 10856016. DOI: 10.3390/ijms25031848.

Elevation of LEM Domain Containing 1 Predicts Poor Prognosis of NSCLC Patients and Triggers Malignant Stemness and Invasion of NSCLC Cells by Stimulating PI3K/AKT Pathway.

Li L, Zhang P Curr Mol Med. 2023; 24(3):366-378.

PMID: 36967459 DOI: 10.2174/1566524023666230324135330.

References

Woo C, Hsu A, Kumar A, Sethi G, Tan K . Thymoquinone inhibits tumor growth and induces apoptosis in a breast cancer xenograft mouse model: the role of p38 MAPK and ROS. PLoS One. 2013; 8(10):e75356. PMC: 3788809. DOI: 10.1371/journal.pone.0075356. View

Larue L, Bellacosa A . Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways. Oncogene. 2005; 24(50):7443-54. DOI: 10.1038/sj.onc.1209091. View

Zhang C, Chen S, Feng Z, Zhao Z, Wang J, Dai D . Laparoscopic versus open gastrectomy for early gastric cancer in Asia: a meta-analysis. Surg Laparosc Endosc Percutan Tech. 2013; 23(4):365-77. DOI: 10.1097/SLE.0b013e31828e3e6e. View

Kawai T, Yanagizawa K, Naito S, Sugimoto H, Fukuzawa M, Gotoda T . Evaluation of gastric cancer diagnosis using new ultrathin transnasal endoscopy with narrow-band imaging: preliminary study. J Gastroenterol Hepatol. 2014; 29 Suppl 4:33-6. DOI: 10.1111/jgh.12797. View

Kalluri R, Weinberg R . The basics of epithelial-mesenchymal transition. J Clin Invest. 2009; 119(6):1420-8. PMC: 2689101. DOI: 10.1172/JCI39104. View

Li X, Xie H, Lei S, Cao H, Meng T, Hu Y . Reduction of CAII Expression in Gastric Cancer: Correlation with Invasion and Metastasis. Chin J Cancer Res. 2013; 24(3):196-200. PMC: 3555285. DOI: 10.1007/s11670-012-0196-6. View

AbuKhader M . Thymoquinone in the clinical treatment of cancer: Fact or fiction?. Pharmacogn Rev. 2013; 7(14):117-20. PMC: 3841989. DOI: 10.4103/0973-7847.120509. View

Tanno B, Sesti F, Cesi V, Bossi G, Ferrari-Amorotti G, Bussolari R . Expression of Slug is regulated by c-Myb and is required for invasion and bone marrow homing of cancer cells of different origin. J Biol Chem. 2010; 285(38):29434-45. PMC: 2937976. DOI: 10.1074/jbc.M109.089045. View

Kalluri R . EMT: when epithelial cells decide to become mesenchymal-like cells. J Clin Invest. 2009; 119(6):1417-9. PMC: 2689122. DOI: 10.1172/JCI39675. View

10.

Gotoda T, Kusano C, Moriyasu F . Future perspective of gastric cancer endotherapy. Ann Transl Med. 2014; 2(3):25. PMC: 4200626. DOI: 10.3978/j.issn.2305-5839.2014.03.03. View

11.

Dergarabetian E, Ghattass K, El-Sitt S, Al-Mismar R, El-Baba C, Itani W . Thymoquinone induces apoptosis in malignant T-cells via generation of ROS. Front Biosci (Elite Ed). 2013; 5(2):706-19. DOI: 10.2741/e651. View

12.

Park J, Ryu K, Eom B, Yoon H, Kim S, Cho S . Proposal of the surgical options for primary tumor control during sentinel node navigation surgery based on the discrepancy between preoperative and postoperative early gastric cancer diagnoses. Ann Surg Oncol. 2013; 21(4):1123-9. DOI: 10.1245/s10434-013-3427-2. View

13.

Rajput S, Prashanth Kumar B, Sarkar S, Das S, Azab B, Santhekadur P . Targeted apoptotic effects of thymoquinone and tamoxifen on XIAP mediated Akt regulation in breast cancer. PLoS One. 2013; 8(4):e61342. PMC: 3629226. DOI: 10.1371/journal.pone.0061342. View

14.

Zhang C, Zeng Y, Li H, Zhao Z, Zhang J, Dai D . Neoadjuvant chemotherapy for nonmetastatic esophago-gastric adenocarcinomas: a systematic review and meta-analysis. Cancer Invest. 2013; 31(6):421-31. DOI: 10.3109/07357907.2013.802801. View

15.

Das A, Bhattacharya A, Chakrabarty S, Ganguli A, Chakrabarti G . Smokeless tobacco extract (STE)-induced toxicity in mammalian cells is mediated by the disruption of cellular microtubule network: a key mechanism of cytotoxicity. PLoS One. 2013; 8(7):e68224. PMC: 3708936. DOI: 10.1371/journal.pone.0068224. View

16.

Amin B, Hosseinzadeh H . Black Cumin (Nigella sativa) and Its Active Constituent, Thymoquinone: An Overview on the Analgesic and Anti-inflammatory Effects. Planta Med. 2015; 82(1-2):8-16. DOI: 10.1055/s-0035-1557838. View

17.

Zhao X, Li X, Yuan H . microRNAs in gastric cancer invasion and metastasis. Front Biosci (Landmark Ed). 2013; 18(3):803-10. DOI: 10.2741/4144. View

18.

Zhu W, Wang J, Guo X, Liu Z, Dong W . Thymoquinone inhibits proliferation in gastric cancer via the STAT3 pathway in vivo and in vitro. World J Gastroenterol. 2016; 22(16):4149-59. PMC: 4837432. DOI: 10.3748/wjg.v22.i16.4149. View

19.

Neiva K, Zhang Z, Miyazawa M, Warner K, Karl E, Nor J . Cross talk initiated by endothelial cells enhances migration and inhibits anoikis of squamous cell carcinoma cells through STAT3/Akt/ERK signaling. Neoplasia. 2009; 11(6):583-93. PMC: 2685447. DOI: 10.1593/neo.09266. View

20.

Schneider-Stock R, Fakhoury I, Zaki A, El-Baba C, Gali-Muhtasib H . Thymoquinone: fifty years of success in the battle against cancer models. Drug Discov Today. 2013; 19(1):18-30. DOI: 10.1016/j.drudis.2013.08.021. View